Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Human papillomavirus and squamous cell carcinoma of the urinary bladder: DaBlaCa-10 study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Risk of recurrence and long-term mortality following radical cystectomy for bladder cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Risk of recurrence and long-term mortality following radical cystectomy for bladder cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term Renal Function following Radical Cystectomy for Bladder Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: To evaluate a potential association between Human Papillomavirus (H.P.V.) and squamous cell carcinoma (S.C.C.) urinary bladder cancer (B.C.). Furthermore, the relation between p16INK4a, H.P.V. and B.C. was examined.

PATIENTS AND METHODS: Patients were included and divided into three groups based on the histological diagnosis of B.C.

SPECIMENS: An extensive exclusion was performed, including accepted casual risk factors for S.C.C. B.C., such as long-term use of catheters, cystolithiasis and Schistosoma hematobium infection. A total of 100 patients were included: 50 with pure S.C.C., 25 with urothelial carcinomas (U.C.) and 25 with squamous differentiation of U.C. (Sq.D.). The patients were operated at one of four major Danish hospitals in the period January 2005 to December 2016. Clinical information was collected from the medical records. Presence of H.P.V. was analyzed using the INNO-LiPA H.P.V. Genotyping Extra II. p16INK4a was analyzed using immunohistochemical (I.H.C.) staining. A p-value <0.05 was considered statistically significant.

RESULTS: An overall H.P.V. prevalence of 12/100 (12%) was observed. H.P.V. was demonstrated in 9/50 (18%) of the S.C.C.

PATIENTS: Overall, p16INK4a over-expression was observed in 52/100 (52%) patients. However, concomitant H.P.V. positivity and p16INK4a over-expression were observed in only 4/100 (4%) patients.

CONCLUSION: The presence of H.P.V. in one fifth of patients with S.C.C. B.C. was demonstrated. H.P.V. infection could have a significant association with S.C.C. B.C. without other known casual risk factors for S.C.C. B.C.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Urology
Vol/bind52
Udgave nummer5-6
Sider (fra-til)371-376
ISSN2168-1805
DOI
StatusUdgivet - 2019

ID: 56245976